Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 14Recruiting 11Active not recruiting 7Withdrawn 3Terminated 3Unknown 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 4Breast 3Tumor-Agnostic 2Other hematologic neoplasm 2Gynecologic 2Gastrointestinal 2CNS 2Head & Neck 1Endocrine 1

Conditions

Breast Neoplasms 3Patient Compliance 1Lung Neoplasms 1Brain Neoplasms 1

Interventions

Trastuzumab 86Cyclophosphamide 67Capecitabine 67Paclitaxel 63Docetaxel 57Fulvestrant 52Letrozole 50Carboplatin 42pembrolizumab 40Lapatinib 38Doxorubicin 36Anastrozole 32Vinorelbine 31Bevacizumab 31exemestane 28Tamoxifen 25Gemcitabine 25Albumin-Bound Paclitaxel 25Radiotherapy 21Taxes 18atezolizumab 17Everolimus 17130-nm albumin-bound paclitaxel 17pertuzumab 16Epirubicin 16palbociclib 15eribulin 14Magnetic Resonance Spectroscopy 14Ado-Trastuzumab Emtansine 14Goserelin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interviews as Topic × Breast × Clear all
NCT01780064 2026-03-18

APAPI

Centre Oscar Lambret

Phase NA Terminated
128 enrolled
Breast

Breast Neoplasms

NCT06315296 2026-03-03

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Thomas Jefferson University

Phase NA Terminated
1 enrolled
BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

NCT04142476 2025-02-17

HORMONOVILLE

Centre Georges Francois Leclerc

Phase NA Terminated
105 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡